This website uses cookies primarily for visitor analytics. Certain pages will ask you to fill in contact details to receive additional information. On these pages you have the option of having the site log your details for future visits. Indicating you want the site to remember your details will place a cookie on your device. To view our full cookie policy, please click here. You can also view it at any time by going to our Contact Us page.

Scientists develop revolutionary heart attack sensor

07 September 2016

Researchers developed a tiny electric sensor, which could potentially improve patient survival rates by telling doctors if a person has had a heart attack.

Image courtesy of Manchester University

An international collaboration of scientists involving a team of researchers at Manchester led by Dr David J. Lewis developed this tiny electric sensor because cardiovascular diseases account for around 30 percent of adult deaths in the 30-70 year age group, which is greater than the combined deaths from all types of cancer. The ability to diagnose cardiac disease is therefore of utmost concern to doctors. When someone has a heart attack, certain chemicals are released into their bloodstream in elevated amounts, and blood tests are therefore the key to diagnosis. 

Dr Lewis, from Manchester’s School of Materials, has worked with his colleagues and a team at India’s Institute of Nano Science and Technology (INST) since 2014 to develop a nanoscale sensor made from ‘few-layer black phosphorus’, a new 2D material, which was coated in DNA. The immobilised DNA binds to a chemical called myoglobin, which increases in blood plasma after a heart attack and can be detected and measured by a simple electrical test.

This could have a major impact, as it is potentially the most rapid, sensitive, selective and accurate method currently available to detect if someone has elevated levels of myoglobin – the measurement of which is one of the methods used in hospitals to check if someone has suffered a heart attack. The researchers predict that its eventual introduction into the clinic could potentially improve patient survival rates after an attack.

This work is the first example of 2D few-layer black phosphorus being used as a biological sensing platform. The test could eventually be used at the patient bedside, and does not require the use of centralised laboratories that may slow down their diagnosis. As the DNA used is developed using chemical information imparted to it by the biological target, it is potentially a universal system that could be applied to other targets beyond myoglobin.

Their work is described in detail in the American Chemical Society journal.


Print this page | E-mail this page